- Home
- CSCI vs MTEM Comparison
CSCI vs MTEM Comparison
Compare CSCI & MTEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSCI
- MTEM
- Stock Information
- Founded
- CSCI 1990
- MTEM 2001
- Country
- CSCI Canada
- MTEM United States
- Employees
- CSCI N/A
- MTEM N/A
- Industry
- CSCI
- MTEM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CSCI
- MTEM Health Care
- Exchange
- CSCI NYSE
- MTEM Nasdaq
- Market Cap
- CSCI 12.5M
- MTEM 10.1M
- IPO Year
- CSCI 1996
- MTEM N/A
- Fundamental
- Price
- CSCI $3.70
- MTEM $1.46
- Analyst Decision
- CSCI
- MTEM
- Analyst Count
- CSCI 0
- MTEM 0
- Target Price
- CSCI N/A
- MTEM N/A
- AVG Volume (30 Days)
- CSCI 5.3K
- MTEM 53.2K
- Earning Date
- CSCI 11-07-2024
- MTEM 11-11-2024
- Dividend Yield
- CSCI N/A
- MTEM N/A
- EPS Growth
- CSCI N/A
- MTEM N/A
- EPS
- CSCI N/A
- MTEM N/A
- Revenue
- CSCI $4,915,000.00
- MTEM $25,470,000.00
- Revenue This Year
- CSCI N/A
- MTEM N/A
- Revenue Next Year
- CSCI N/A
- MTEM N/A
- P/E Ratio
- CSCI N/A
- MTEM N/A
- Revenue Growth
- CSCI N/A
- MTEM N/A
- 52 Week Low
- CSCI $3.49
- MTEM $1.00
- 52 Week High
- CSCI $11.10
- MTEM $6.90
- Technical
- Relative Strength Index (RSI)
- CSCI N/A
- MTEM 56.08
- Support Level
- CSCI N/A
- MTEM $1.21
- Resistance Level
- CSCI N/A
- MTEM $1.37
- Average True Range (ATR)
- CSCI 0.00
- MTEM 0.09
- MACD
- CSCI 0.00
- MTEM 0.02
- Stochastic Oscillator
- CSCI 0.00
- MTEM 96.23
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.
About MTEM Molecular Templates Inc.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.